BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stanley C, O'Sullivan SE. Vascular targets for cannabinoids: animal and human studies. Br J Pharmacol 2014;171:1361-78. [PMID: 24329566 DOI: 10.1111/bph.12560] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Szekeres M, Nádasy GL, Soltész-Katona E, Hunyady L. Control of myogenic tone and agonist induced contraction of intramural coronary resistance arterioles by cannabinoid type 1 receptors and endocannabinoids. Prostaglandins Other Lipid Mediat 2018;134:77-83. [PMID: 29031792 DOI: 10.1016/j.prostaglandins.2017.10.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
2 Chiocchetti R, Galiazzo G, Tagliavia C, Stanzani A, Giancola F, Menchetti M, Militerno G, Bernardini C, Forni M, Mandrioli L. Cellular Distribution of Canonical and Putative Cannabinoid Receptors in Canine Cervical Dorsal Root Ganglia. Front Vet Sci 2019;6:313. [PMID: 31608295 DOI: 10.3389/fvets.2019.00313] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
3 Stanley CP, Hind WH, Tufarelli C, O'Sullivan SE. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation. Cardiovasc Res 2015;107:568-78. [PMID: 26092099 DOI: 10.1093/cvr/cvv179] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
4 Hommer N, Schmidl D, Kallab M, Bauer M, Werkmeister RM, Schmetterer L, Abensperg-Traun M, Garhöfer G. The Effect of Orally Administered Low-Dose Dronabinol on Retinal Blood Flow and Oxygen Metabolism in Healthy Subjects. J Ocul Pharmacol Ther 2021;37:360-6. [PMID: 33999707 DOI: 10.1089/jop.2020.0131] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Szekeres M, Nádasy GL, Turu G, Soltész-Katona E, Benyó Z, Offermanns S, Ruisanchez É, Szabó E, Takáts Z, Bátkai S, Tóth ZE, Hunyady L. Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension. Mol Cell Endocrinol 2015;403:46-56. [PMID: 25595485 DOI: 10.1016/j.mce.2015.01.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
6 Greig FH, Nather K, Ballantyne MD, Kazi ZH, Alganga H, Ewart MA, Zaborska KE, Fertig B, Pyne NJ, Pyne S, Kennedy S. Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse. Eur J Pharmacol 2019;842:1-9. [PMID: 30359564 DOI: 10.1016/j.ejphar.2018.10.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Hill M, Wong TY, Davis M, Meier MH. Associations between cannabis use and retinal vessel diameter in young adults. Schizophrenia Research 2020;219:62-8. [DOI: 10.1016/j.schres.2019.02.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Wang DP, Lin Q, Kang K, Wu YF, Su SH, Hai J. Preservation of spatial memory and neuroprotection by the fatty acid amide hydrolase inhibitor URB597 in a rat model of vascular dementia. Ann Transl Med 2021;9:228. [PMID: 33708855 DOI: 10.21037/atm-20-4431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Karpińska O, Baranowska-Kuczko M, Kloza M, Kozłowska H. Endocannabinoids modulate Gq/11 protein-coupled receptor agonist-induced vasoconstriction via a negative feedback mechanism. J Pharm Pharmacol 2018;70:214-22. [PMID: 29148061 DOI: 10.1111/jphp.12854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
10 Gruden G, Barutta F, Kunos G, Pacher P. Role of the endocannabinoid system in diabetes and diabetic complications. Br J Pharmacol 2016;173:1116-27. [PMID: 26076890 DOI: 10.1111/bph.13226] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 12.7] [Reference Citation Analysis]
11 del Río C, Navarrete C, Collado JA, Bellido ML, Gómez-Cañas M, Pazos MR, Fernández-Ruiz J, Pollastro F, Appendino G, Calzado MA, Cantarero I, Muñoz E. The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways. Sci Rep 2016;6:21703. [PMID: 26887982 DOI: 10.1038/srep21703] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 10.0] [Reference Citation Analysis]
12 Richards JR. Mechanisms for the Risk of Acute Coronary Syndrome and Arrhythmia Associated With Phytogenic and Synthetic Cannabinoid Use. J Cardiovasc Pharmacol Ther 2020;25:508-22. [PMID: 32588641 DOI: 10.1177/1074248420935743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Agar E. The role of cannabinoids and leptin in neurological diseases. Acta Neurol Scand 2015;132:371-80. [PMID: 25880465 DOI: 10.1111/ane.12411] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
14 Hassan Almalki W, Alzahrani A, Mahmoud El-Daly ME, Faissal Fadel Ahmed AH. A molecular explanation of cardiovascular protection through abnormal cannabidiol: Involving the dysfunctional β-adrenergic and ATP-sensitive K+ channel activity in cardiovascular compromised preterm infants. J Biochem Mol Toxicol 2021;:e22849. [PMID: 34309957 DOI: 10.1002/jbt.22849] [Reference Citation Analysis]
15 Reece AS, Norman A, Hulse GK. Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: a longitudinal study. BMJ Open 2016;6:e011891. [PMID: 27821595 DOI: 10.1136/bmjopen-2016-011891] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
16 Chia CW, Egan JM, Ferrucci L. Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk. Circ Res 2018;123:886-904. [PMID: 30355075 DOI: 10.1161/CIRCRESAHA.118.312806] [Cited by in Crossref: 63] [Cited by in F6Publishing: 34] [Article Influence: 31.5] [Reference Citation Analysis]
17 Karpińska O, Baranowska-Kuczko M, Kloza M, Ambroz Ewicz E, Kozłowski T, Kasacka I, Malinowska B, Kozłowska H. Activation of CB1 receptors by 2-arachidonoylglycerol attenuates vasoconstriction induced by U46619 and angiotensin II in human and rat pulmonary arteries. Am J Physiol Regul Integr Comp Physiol 2017;312:R883-93. [PMID: 28356298 DOI: 10.1152/ajpregu.00324.2016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
18 Biernacki M, Ambrożewicz E, Gęgotek A, Toczek M, Skrzydlewska E. Long-term administration of fatty acid amide hydrolase inhibitor (URB597) to rats with spontaneous hypertension disturbs liver redox balance and phospholipid metabolism. Adv Med Sci 2019;64:15-23. [PMID: 30243113 DOI: 10.1016/j.advms.2018.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
19 Argueta DA, Aich A, Muqolli F, Cherukury H, Sagi V, DiPatrizio NV, Gupta K. Considerations for Cannabis Use to Treat Pain in Sickle Cell Disease. J Clin Med 2020;9:E3902. [PMID: 33271850 DOI: 10.3390/jcm9123902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Polat N, Cumurcu B, Cumurcu T, Tuncer İ. Corneal endothelial changes in long-term cannabinoid users. Cutaneous and Ocular Toxicology 2018;37:19-23. [DOI: 10.1080/15569527.2017.1322098] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
21 Ma H, He K, Zhu J, Li X, Ye X. The anti-hyperglycemia effects of Rhizoma Coptidis alkaloids: A systematic review of modern pharmacological studies of the traditional herbal medicine. Fitoterapia 2019;134:210-20. [PMID: 30836124 DOI: 10.1016/j.fitote.2019.03.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
22 Solar P, Mackerle Z, Joukal M, Jancalek R. Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review. Neurosurg Rev 2021;44:649-58. [PMID: 32124117 DOI: 10.1007/s10143-020-01276-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 O'Sullivan SE. Endocannabinoids and the Cardiovascular System in Health and Disease. Handb Exp Pharmacol 2015;231:393-422. [PMID: 26408169 DOI: 10.1007/978-3-319-20825-1_14] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
24 Bi H, Cai D, Zhang R, Zhu Y, Zhang D, Qiao L, Liu Y. Mass spectrometry-based metabolomics approach to reveal differential compounds in pufferfish soups: Flavor, nutrition, and safety. Food Chemistry 2019;301:125261. [DOI: 10.1016/j.foodchem.2019.125261] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
25 Latorre JG, Schmidt EB. Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System. Curr Cardiol Rep 2015;17:627. [PMID: 26238742 DOI: 10.1007/s11886-015-0627-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
26 Miklós Z, Wafa D, Nádasy GL, Tóth ZE, Besztercei B, Dörnyei G, Laska Z, Benyó Z, Ivanics T, Hunyady L, Szekeres M. Angiotensin II-Induced Cardiac Effects Are Modulated by Endocannabinoid-Mediated CB1 Receptor Activation. Cells 2021;10:724. [PMID: 33805075 DOI: 10.3390/cells10040724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zantut PRA, Veras MM, Yariwake VY, Takahashi WY, Saldiva PH, Young LH, Damico FM, Fajersztajn L. Effects of cannabis and its components on the retina: a systematic review. Cutan Ocul Toxicol 2020;39:1-9. [PMID: 31648567 DOI: 10.1080/15569527.2019.1685534] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Wheal AJ, Cipriano M, Fowler CJ, Randall MD, O'Sullivan SE. Cannabidiol improves vasorelaxation in Zucker diabetic fatty rats through cyclooxygenase activation. J Pharmacol Exp Ther 2014;351:457-66. [PMID: 25212218 DOI: 10.1124/jpet.114.217125] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
29 Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med 2014;370:2219-27. [PMID: 24897085 DOI: 10.1056/NEJMra1402309] [Cited by in Crossref: 1228] [Cited by in F6Publishing: 635] [Article Influence: 175.4] [Reference Citation Analysis]
30 Navarro-Dorado J, Villalba N, Prieto D, Brera B, Martín-Moreno AM, Tejerina T, de Ceballos ML. Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists. Front Neurosci 2016;10:422. [PMID: 27695396 DOI: 10.3389/fnins.2016.00422] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
31 Puhl SL. Cannabinoid-sensitive receptors in cardiac physiology and ischaemia. Biochim Biophys Acta Mol Cell Res 2020;1867:118462. [PMID: 30890410 DOI: 10.1016/j.bbamcr.2019.03.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
32 Valencia-Guzmán CJ, Castro-Ruiz JE, García-Gasca T, Rojas-Molina A, Romo-Mancillas A, Luna-Vázquez FJ, Rojas-Molina JI, Ibarra-Alvarado C. Endothelial TRP channels and cannabinoid receptors are involved in affinin-induced vasodilation. Fitoterapia 2021;153:104985. [PMID: 34237389 DOI: 10.1016/j.fitote.2021.104985] [Reference Citation Analysis]
33 Benyó Z, Ruisanchez É, Leszl-Ishiguro M, Sándor P, Pacher P. Endocannabinoids in cerebrovascular regulation. Am J Physiol Heart Circ Physiol 2016;310:H785-801. [PMID: 26825517 DOI: 10.1152/ajpheart.00571.2015] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
34 Ni WJ, Tang LQ, Zhou H, Ding HH, Qiu YY. Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats. J Cell Mol Med 2016;20:1491-502. [PMID: 27098986 DOI: 10.1111/jcmm.12837] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
35 Martín Giménez VM, Russo MG, Narda GE, Fuentes LB, Mazzei L, Gamarra-Luques C, Kassuha DE, Manucha W. Synthesis, physicochemical characterisation and biological activity of anandamide/ɛ-polycaprolactone nanoparticles obtained by electrospraying. IET Nanobiotechnol 2020;14:86-93. [PMID: 31935683 DOI: 10.1049/iet-nbt.2019.0108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
36 Jayaraman A, Kumar P, Marin S, de Atauri P, Mateo F, M Thomson T, J Centelles J, F Graham S, Cascante M. Untargeted metabolomics reveals distinct metabolic reprogramming in endothelial cells co-cultured with CSC and non-CSC prostate cancer cell subpopulations. PLoS One 2018;13:e0192175. [PMID: 29466368 DOI: 10.1371/journal.pone.0192175] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
37 Hermanns-clausen M, Kithinji J, Spehl M, Angerer V, Franz F, Eyer F, Auwärter V. Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project: Case series of JWH-210 intoxications. Drug Test Analysis 2016;8:1030-8. [DOI: 10.1002/dta.1936] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
38 Latif Z, Garg N. The Impact of Marijuana on the Cardiovascular System: A Review of the Most Common Cardiovascular Events Associated with Marijuana Use. J Clin Med 2020;9:E1925. [PMID: 32575540 DOI: 10.3390/jcm9061925] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
39 Pacher P, Steffens S, Haskó G, Schindler TH, Kunos G. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nat Rev Cardiol 2018;15:151-66. [DOI: 10.1038/nrcardio.2017.130] [Cited by in Crossref: 151] [Cited by in F6Publishing: 133] [Article Influence: 37.8] [Reference Citation Analysis]
40 Bakali E, McDonald J, Elliott RA, Lambert DG, Tincello DG. Cannabinoid receptor expression in the bladder is altered in detrusor overactivity. Int Urogynecol J 2016;27:129-39. [PMID: 26224382 DOI: 10.1007/s00192-015-2802-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
41 Kicman A, Toczek M. The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease. Int J Mol Sci 2020;21:E6740. [PMID: 32937917 DOI: 10.3390/ijms21186740] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
42 Stanley CP, Hind WH, Tufarelli C, O'Sullivan SE. The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries. Pharmacol Res 2016;113:356-63. [PMID: 27633407 DOI: 10.1016/j.phrs.2016.08.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
43 Sánchez Artiles AE, Awan A, Karl M, Santini A. Cardiovascular effects of cannabis (marijuana): A timely update. Phytother Res 2019;33:1592-4. [PMID: 30761633 DOI: 10.1002/ptr.6315] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
44 Hommer N, Kallab M, Szegedi S, Puchner S, Stjepanek K, Bauer M, Werkmeister RM, Schmetterer L, Abensperg-Traun M, Garhöfer G, Schmidl D. The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects-A Randomized Clinical Trial. Clin Pharmacol Ther 2020;108:155-61. [PMID: 31977076 DOI: 10.1002/cpt.1797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
45 Manolis TA, Manolis AA, Manolis AS. Cannabis Associated "High" Cardiovascular Morbidity and Mortality: Marijuana Smoke Like Tobacco Smoke? A Déjà Vu/Déjà Vécu Story? Mini Rev Med Chem 2019;19:870-9. [PMID: 30426899 DOI: 10.2174/1389557518666181114113947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
46 Seleverstov O, Tobiasz A, Jackson JS, Sullivan R, Ma D, Sullivan JP, Davison S, Akkhawattanangkul Y, Tate DL, Costello T, Barnett S, Li W, Mari G, Dopico AM, Bukiya AN. Maternal alcohol exposure during mid-pregnancy dilates fetal cerebral arteries via endocannabinoid receptors. Alcohol 2017;61:51-61. [PMID: 28554529 DOI: 10.1016/j.alcohol.2017.01.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
47 Alfulaij N, Meiners F, Michalek J, Small-Howard AL, Turner HC, Stokes AJ. Cannabinoids, the Heart of the Matter. J Am Heart Assoc 2018;7:e009099. [PMID: 30006489 DOI: 10.1161/JAHA.118.009099] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
48 Vella RK, Jackson DJ, Fenning AS. Δ9-Tetrahydrocannabinol Prevents Cardiovascular Dysfunction in STZ-Diabetic Wistar-Kyoto Rats. Biomed Res Int 2017;2017:7974149. [PMID: 29181404 DOI: 10.1155/2017/7974149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
49 Tischmann L, Drummen M, Joris PJ, Gatta-Cherifi B, Raben A, Fogelholm M, Matias I, Cota D, Mensink RP, Westerterp-Plantenga MS, Adam TC. Effects of a High-Protein Diet on Cardiometabolic Health, Vascular Function, and Endocannabinoids-A PREVIEW Study. Nutrients 2020;12:E1512. [PMID: 32455987 DOI: 10.3390/nu12051512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Malinowska B, Toczek M, Pędzińska-Betiuk A, Schlicker E. Cannabinoids in arterial, pulmonary and portal hypertension - mechanisms of action and potential therapeutic significance. Br J Pharmacol 2019;176:1395-411. [PMID: 29455452 DOI: 10.1111/bph.14168] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
51 Sainz-Cort A, Heeroma JH. The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection. J Cannabis Res 2020;2:23. [PMID: 32835160 DOI: 10.1186/s42238-020-00030-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]